We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Opiant Pharmaceuticals Inc | NASDAQ:OPNT | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 20.65 | 18.89 | 22.41 | 0 | 01:00:00 |
From May 2021 to May 2024
The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Thursday, November 11, 2021 to discuss the results and operational progress.
To access the call, please dial 877-407-0792 in the U.S. or 201-689-8263 outside the U.S. and provide the conference ID number: 13723604. To access the live webcast, please visit http://public.viavid.com/index.php?id=146696. Following the live webcast, an archived version of the call will be available on the website.
Thursday November 11 @ 4:30 pm ET
| Domestic: | 877-407-0792 |
| International: | 201-689-8263 |
| Conference ID: | 13723604 |
| Webcast: | http://public.viavid.com/index.php?id=146696 |
About Opiant Pharmaceuticals, Inc.Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com and follow Opiant on Twitter (@Opiant_Pharma).
For Media and Investor Inquiries:Ben Atkins, Opiant(310) 598-5410batkins@opiant.com
1 Year Opiant Pharmaceuticals Chart |
1 Month Opiant Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
